Skip to navigation Skip to content


Master Page Does Not Exist

Chapter eNews

facebook  Twitter  YouTube icon 2  Flickr  WAS_2013_Walk_blogger-icon  Contact us         

December 2014

Master Page Does Not Exist

November is the month where we look back at the year and remember all the things, big and little, for which we're thankful. We don't have to be reminded of who we need to thank this and every year ... YOU! Together, we can create a world free of MS.

Let us know what you think about this newsletter by filling out our feedback form and sign up to receive the monthly Chapter eNews.

Sign Up for Emails

In this article

Coping with holiday stress

Holiday Stress

The holidays are a time to focus on family, friends, feasting and unforgettable memories. But, along with all the memory-making dinners and parties can come extra work and worry. Coping with extra stress can be difficult for anyone and many people with MS say they experience more symptoms during stressful times. This year, prepare for the holiday season with some helpful tips on how to tame stress and manage your holiday dinner.

Read More

Tomorrow is #GivingTuesday


Black Friday, Cyber Monday, and... #GivingTuesday! Join other charities, families, businesses and individuals to help create a national moment around the holidays dedicated to giving rather than shopping. Please remember the National MS Society and give back to your community tomorrow.


Tis' the season


#GivingTuesday isn't the only way to give back this holiday season.

  • Workplace Giving: Designate the National MS Society through your workplace giving program. CFC Code: 95694. EIN: 91-0742424.
  • AmazonSmile: Shopping online for the holidays this year? Designate the National MS Society, Greater Northwest Chapter as your preferred charity at and a portion of eligible purchases will be automatically donated to support our local work (at no cost to you!). Be sure to bookmark the page for future purchases, too – AmazonSmile works year-round!

FDA approves Lemtrada™ (alemtuzumab) for relapsing MS


The U.S. Food and Drug Administration has approved Lemtrada™ (alemtuzumab, Genzyme, a Sanofi Company) as a disease-modifying therapy for people with relapsing forms of MS. "The FDA approval of Lemtrada is a significant milestone for people living with relapsing MS in the United States," said Dr. Timothy Coetzee, Chief Advocacy, Services and Research Officer at the National MS Society.

Read More

Master Page Does Not Exist


Chapter Home Chapter eNews
Master Page Does Not Exist
Master Page Does Not Exist